Search Results - "Duvoux, C."

Renal Function at Two Years in Liver Transplant Patients Receiving Everolimus: Results of a Randomized, Multicenter Study by Saliba, F., De Simone, P., Nevens, F., De Carlis, L., Metselaar, H. J., Beckebaum, S., Jonas, S., Sudan, D., Fischer, L., Duvoux, C., Chavin, K. D., Koneru, B., Huang, M. A., Chapman, W. C., Foltys, D., Dong, G., Lopez, P. M., Fung, J., Junge, G.

“…In a 24‐month prospective, randomized, multicenter, open‐label study, de novo liver transplant patients were randomized at 30 days to everolimus (EVR) +…”
Get full text

Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial by De Simone, P., Nevens, F., De Carlis, L., Metselaar, H. J., Beckebaum, S., Saliba, F., Jonas, S., Sudan, D., Fung, J., Fischer, L., Duvoux, C., Chavin, K. D., Koneru, B., Huang, M. A., Chapman, W. C., Foltys, D., Witte, S., Jiang, H., Hexham, J. M., Junge, G.

“…In a prospective, multicenter, open‐label study, de novo liver transplant patients were randomized at day 30±5 to (i) everolimus initiation with tacrolimus…”
Get full text

Efficacy and Safety of Everolimus and Mycophenolic Acid With Early Tacrolimus Withdrawal After Liver Transplantation: A Multicenter Randomized Trial by Saliba, F., Duvoux, C., Gugenheim, J., Kamar, N., Dharancy, S., Salamé, E., Neau‐Cransac, M., Durand, F., Houssel‐Debry, P., Vanlemmens, C., Pageaux, G., Hardwigsen, J., Eyraud, D., Calmus, Y., Di Giambattista, F., Dumortier, J., Conti, F.

“…SIMCER was a 6‐mo, multicenter, open‐label trial. Selected de novo liver transplant recipients were randomized (week 4) to everolimus with low‐exposure…”
Get full text

Reduced‐Dose Tacrolimus with Mycophenolate Mofetil vs. Standard‐Dose Tacrolimus in Liver Transplantation: A Randomized Study by Boudjema, K., Camus, C., Saliba, F., Calmus, Y., Salamé, E., Pageaux, G., Ducerf, C., Duvoux, C., Mouchel, C., Renault, A., Compagnon, P., Lorho, R., Bellissant, E.

“…We conducted a multicenter randomized study in liver transplantation to compare standard‐dose tacrolimus to reduced‐dose tacrolimus with mycophenolate mofetil…”
Get full text

The optimal timing of hepatitis C therapy in liver transplant‐eligible patients: Cost‐effectiveness analysis of new opportunities by Cortesi, P. A., Belli, L. S., Facchetti, R., Mazzarelli, C., Perricone, G., De Nicola, S., Cesana, G., Duvoux, C., Mantovani, L. G., Strazzabosco, M.

“…Summary Different strategies of DAAs treatment are currently possible both pre‐ and postliver transplantation (LT). Clinical and economic consequences of these…”
Get full text

Immunosuppression in liver transplant recipients with renal impairment by Duvoux, C, Pageaux, G.P

Get full text

Safety of sofosbuvir‐based regimens after liver transplantation: longitudinal assessment of renal function in the prospective ANRS CO23 CUPILT study by Anty, R., Favre, G., Coilly, A., Rossignol, E., Houssel‐Debry, P., Duvoux, C., De Ledinghen, V., Di Martino, V., Leroy, V., Radenne, S., Kamar, N., Canva, V., D'Alteroche, L., Durand, F., Dumortier, J., Lebray, P., Besch, C., Tran, A., Canivet, C. M., Botta‐Fridlund, D., Montialoux, H., Moreno, C., Conti, F., Silvain, C., Perré, P., Habersetzer, F., Abergel, A., Debette‐Gratien, M., Dharancy, S., Esnault, V. L. M., Fougerou‐Leurent, C., Cagnot, C., Diallo, A., Veislinger, A., Danjou, H., Samuel, D., Pageaux, G.‐P., Duclos‐Vallée, J.‐C.

“…Summary Background In liver transplant recipients with hepatitis C virus recurrence, there is concern about renal safety of sofosbuvir‐based regimens. Changes…”
Get full text

Impact on Renal Function of Stepwise Withdrawal of Tacrolimus Combined with Everolimus and EC-MPS vs Standard Treatment Combining Tacrolimus and EC-MPS in De Novo Liver Transplant Recipients: Results of the Simcer Study by Conti, F, Saliba, F, Duvoux, C, Dharancy, S, Dumortier, J, Di Giambattista, F, Calmus, Y

Get full text

Factors associated with tumor recurrence after liver transplantation for hepatocellular carcinoma: prospective cohort on 371 patients by Decaens, T, Adam, R, Dharancy, S, Sulpice, L, Samuel, D, Boleslawski, E, Latournerie, M, Pageaux, G.-P, Scatton, O, Radenne, S, Savier, E, Belghiti, J, Vanlemens, C, Oubaya, N, Duvoux, C

Get full text

Delisting of liver transplant candidates with chronic hepatitis C virus infection after viral eradication: outcome after delisting: a European study by Belli, L.S, Berenguer, M, Cortesi, P.A, Facchetti, R, Strazzabosco, M, Perricone, G, Rockenschaub, S.-R, Martini, S, Morelli, C, Donato, F, Volpes, R, Pageaux, G.-P, Coilly, A, Fagiuoli, S, Berlakovich, G, Monico, S, Vinaixa, C, Polak, W, Duvoux, C

Get full text

P0039 : Prediction of HCC recurrence after liver transplantation based on explants pathology: Comparison of prediction accuracy of 4 prognostic models in a prospective external cohort by Costentin, C.E, Roudot-Thoroval, F, Decaens, T, Calderaro, J, Luciani, A, Amaddeo, G, Laurent, A, Duvoux, C

Get full text

Impact of Direct Anti-Viral Agents on Inactivation/De-Listing of Liver Transplant Candidates Listed for Decompensated C Cirrhosis: A European Study by Belli, L.S, Berenguer, M, Rockenschaub, S.-R, Martini, S, Morelli, C, Donato, F, Volpes, R, Pageaux, G.-P, Coilly, A, Fagiuoli, S, Cortesi, P, Duvoux, C

Get full text

Long-Term Outcome in Liver Transplantation Candidates with Portopulmonary Hypertension by Savale, L, Sattler, C, Calmus, Y, Duvoux, C, Durand, F, Conti, F, Feray, C, Francoz, C, Hervé, P, Samuel, D, Duclos-Vallée, J.C, Sitbon, O

Get full text

P0387 : Identification of optimal cut-offs in alpha-fetoprotein and the “AFP Score” to maximise the accuracy of selection of liver transplant candidates with hepatocellular carcinoma by Rowe, I.A, Tsochatzis, E, Shah, M, Haldar, D, Houlihan, D, Davies, S, Godfrey, E, Shetty, S, O’Beirne, J, Mergental, H, Duvoux, C, Burroughs, A, Hoare, M, Shah, T

Get full text

Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2) by Levy, G, Burra, P, Cavallari, A, Duvoux, C, Lake, J, Mayer, A D, Mies, S, Pollard, S G, Varo, E, Villamil, F, Johnston, A

“…A prospective, open-label, study was conducted at 29 centers in 9 countries, involving 307 de novo liver transplant patients to compare the clinical usefulness…”
Get full text

High Efficacy of Ledipasvir/Sofosbuvir Plus Ribavirin among Patients with Decompensated Cirrhosis who Underwent Liver Transplant during Participation in the Solar-1 and -2 Studies by Müllhaupt, B, Kwo, P, Agarwal, K, Duvoux, C, Durand, F, Peck-Radosavljevic, M, Yoshida, E.M, Lilly, L, Willems, B, Vargas, H, Kumar, P, Brown, R.S, Horsmans, Y, De-Oertel, S, Arterburn, S, Dvory-Sobol, H, Brainard, D.M, McHutchison, J.G, Terrault, N, Rizzetto, M

Get full text

Validation of 2 Explant-Based Recurrence Prognostic Models after Liver Transplantation for Hepatocellular Carcinoma in an External Cohort by Costentin, C, Notarpaolo, A, Boudjema, K, Magini, G, Bachellier, P, Meglioresi, L, Muscari, F, Gambato, M, Salame, E, Manenti, F, Bernard, P.H, D’Ambrosio, C, Ettore, G.M, Francoz, C, Vitale, A, Dharancy, S, Burra, P, Vanlemmens, C, Fagiuoli, S, Laurent, A, Radenne, S, Dumortier, J, Hilleret, M.N, Decaens, T, Calderaro, J, Amaddeo, G, Roudot-Thoraval, F, Duvoux, C

Get full text

Treatment and prognosis of acute severe autoimmune hepatitis by De Martin, E, Coilly, A, Houssel-Debry, P, Ollivier-Hourmand, I, Heurgue-Berlot, A, Artru, F, Barge, S, Chazouilleres, O, Silvain, C, Duvoux, C, Pageaux, G.-P, Besch, C, Bourlière, M, Fontaine, H, de Ledinghen, V, Dumortier, J, Conti, F, Radenne, S, Debette-Gratien, M, Goria, O, Boursier, J, Peron, J.-M, Durand, F, Borrentain, P, Potier, P, Minello, A, Abergel, A, Perarnau, J.-M, Nousbaum, J.-B, Rudler, M, Alric, L, Anty, R, Sturm, N, Sebagh, M, Agostini, H, Samuel, D, Duclos-Vallée, J.-C

Get full text

Validation of Mesiah Score System in Patients with Hepatocellular Carcinoma by Yang, J.D, Mara, K, Harmsen, W.S, Therneau, T.M, Peck, M, Stauber, R, Degos, F, Blanc, J.-F, Leroy, V, Trinchet, J.C, Duvoux, C, Assenat, E, Klinker, H, Schott, E, Colombo, M, Izzo, F, Marinho, R.T, Pascual, S, Coll, S, Peña, A.M, Stål, P, Haglund, U, Johnson, P, Evans, J, Meyer, T, Suddle, A, Fenwick, S, Castel, H, Schwartz, M, Gores, G.J, Roberts, L.R

Get full text

Sofosbuvir-Based-Regimen for HCV Recurrence after Combined Liver-Kidney Transplantation : Results from the ANRS CO23 Cupilt Study by Dharancy, S, Coilly, A, Fougerou-Leurent, C, Duvoux, C, Kamar, N, Leroy, V, Tran, A, Houssel-Debry, P, Canva, V, Moreno, C, Conti, F, Dumortier, J, Di Martino, V, Radenne, S, De Ledinghen, V, D’Alteroche, L, Silvain, C, Besch, C, Perré, P, Botta-Fridlund, D, Francoz, C, Habersetzer, F, Montialoux, H, Abergel, A, Debette-Gratien, M, Rohel, A, Vallée, J.C.D, Pageaux, G.-P

Get full text